WallStreetZenWallStreetZen

NASDAQ: HUMA
Humacyte Inc Earnings & Revenue

HUMA past revenue growth

How has HUMA's revenue growth performed historically?
Company
-100%
Industry
169.3%
Market
17.86%
HUMA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HUMA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

HUMA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$89.4M
Current Profit Margin
0%

HUMA Return on Equity

Current Company
-120.4%
Current Industry
15.4%
Current Market
-8.4%
HUMA's Return on Equity (-120.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HUMA announces earnings.

HUMA Return on Assets

Current Company
-50.7%
Current Industry
2.2%
HUMA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HUMA Return on Capital Employed

Current Company
-61.74%
Current Industry
17.7%

HUMA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HUMA$0.00-$74.83M-$89.39M-100.00%N/A
ERAS$0.00-$121.31M-$125.04MN/AN/A
RAPT$0.00-$113.25M-$116.80M-100.00%N/A
STRO$153.73M-$66.98M-$106.79M+31.96%N/A
AVIR$0.00-$134.52M-$135.96M-100.00%N/A

HUMA earnings dates

Next earnings date
May 10, 2024

Humacyte Earnings & Revenue FAQ

What were HUMA's earnings last quarter?

On Invalid Date, Humacyte (NASDAQ: HUMA) reported Q3 2023 earnings per share (EPS) of -$0.25, up 0% year over year. Total Humacyte earnings for the quarter were -$26.00 million. In the same quarter last year, Humacyte's earnings per share (EPS) was -$0.25.

If you're new to stock investing, here's how to buy Humacyte stock.

What was HUMA's earnings growth in the past year?

As of Q1 2024, Humacyte's earnings has grown year over year. Humacyte's earnings in the past year totalled -$89.39 million.

What is HUMA's earnings date?

Humacyte's earnings date is Invalid Date. Add HUMA to your watchlist to be reminded of HUMA's next earnings announcement.

What was HUMA's revenue last quarter?

On Invalid Date, Humacyte (NASDAQ: HUMA) reported Q3 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Humacyte's revenue was $31.00 thousand.

What was HUMA's revenue growth in the past year?

As of Q1 2024, Humacyte's revenue has grown -100% year over year. This is 269.3 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Humacyte's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.